These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34169121)

  • 1. Prenatal features and neonatal management of severe hyperparathyroidism caused by the heterozygous inactivating calcium-sensing receptor variant, Arg185Gln: A case report and review of the literature.
    Aubert-Mucca M; Dubucs C; Groussolles M; Vial J; Le Guillou E; Porquet-Bordes V; Pasmant E; Salles JP; Edouard T
    Bone Rep; 2021 Dec; 15():101097. PubMed ID: 34169121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case Report: Severe Neonatal Course in Paternally Derived Familial Hypocalciuric Hypercalcemia.
    Höppner J; Lais S; Roll C; Wegener-Panzer A; Wieczorek D; Högler W; Grasemann C
    Front Endocrinol (Lausanne); 2021; 12():700612. PubMed ID: 34659108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtotal Parathyroidectomy Successfully Controls Calcium Levels of Patients with Neonatal Severe Hyperparathyroidism Carrying a Novel CASR Mutation.
    Wejaphikul K; Dejkhamron P; Khorana J; Watcharachan K; Intachai W; Olsen B; Tongsima S; Ketudat Cairns JR; Ngamphiw C; Kantaputra P
    Horm Res Paediatr; 2023; 96(4):432-438. PubMed ID: 36626889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cinacalcet monotherapy in neonatal severe hyperparathyroidism: a case study and review.
    Gannon AW; Monk HM; Levine MA
    J Clin Endocrinol Metab; 2014 Jan; 99(1):7-11. PubMed ID: 24203066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Unusual Presentations of Loss-of-Function Mutations of the Calcium-Sensing Receptor.
    Palmieri S; Grassi G; Guarnieri V; Chiodini I; Arosio M; Eller-Vainicher C
    Front Med (Lausanne); 2021; 8():809067. PubMed ID: 35141253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal Severe Hyperparathyroidism: Novel Insights From Calcium, PTH, and the CASR Gene.
    Marx SJ; Sinaii N
    J Clin Endocrinol Metab; 2020 Apr; 105(4):1061-78. PubMed ID: 31778168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cinacalcet therapy in a child with novel homozygous CASR p.Glu353Lys mutation causing familial hypocalciuric hypercalcemia type 1: case report and review of the literature.
    Koca SB
    Turk J Pediatr; 2023; 65(5):853-861. PubMed ID: 37853976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation.
    Gulcan-Kersin S; Kirkgoz T; Eltan M; Rzayev T; Ata P; Bilgen H; Ozek E; Bereket A; Turan S
    Horm Res Paediatr; 2020; 93(5):313-321. PubMed ID: 33147586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New mutation in the CASR gene in a family with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT).
    Rodrigues LS; Cáu AC; Bussmann LZ; Bastida G; Brunetto OH; Corrêa PH; Martin RM
    Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):67-71. PubMed ID: 21468522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel case of neonatal severe hyperparathyroidism successfully treated with a type II calcimimetic drug.
    Leunbach TL; Hansen AT; Madsen M; Cipliene R; Christensen PS; Schou AJ
    Bone Rep; 2021 Jun; 14():100761. PubMed ID: 33748353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygous inactivating CaSR mutations causing neonatal hyperparathyroidism: function, inheritance and phenotype.
    Glaudo M; Letz S; Quinkler M; Bogner U; Elbelt U; Strasburger CJ; Schnabel D; Lankes E; Scheel S; Feldkamp J; Haag C; Schulze E; Frank-Raue K; Raue F; Mayr B; Schöfl C
    Eur J Endocrinol; 2016 Nov; 175(5):421-31. PubMed ID: 27666534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene.
    Cole DE; Janicic N; Salisbury SR; Hendy GN
    Am J Med Genet; 1997 Aug; 71(2):202-10. PubMed ID: 9217223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal severe hyperparathyroidism associated with a novel de novo heterozygous R551K inactivating mutation and a heterozygous A986S polymorphism of the calcium-sensing receptor gene.
    Tõke J; Czirják G; Patócs A; Enyedi B; Gergics P; Csákváry V; Enyedi P; Tóth M
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):385-92. PubMed ID: 17555508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism caused by inactivating mutations of calcium-sensing receptor].
    Watanabe S; Fukumoto S
    Nihon Rinsho; 2002 Feb; 60(2):325-30. PubMed ID: 11857921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disorders of the Calcium Sensing Signaling Pathway: From Familial Hypocalciuric Hypercalcemia (FHH) to Life Threatening Conditions in Infancy.
    Höppner J; Sinningen K; Raimann A; Obermayer-Pietsch B; Grasemann C
    J Clin Med; 2022 May; 11(9):. PubMed ID: 35566721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal severe hyperparathyroidism caused by homozygous mutation in CASR: A rare cause of life-threatening hypercalcemia.
    Murphy H; Patrick J; Báez-Irizarry E; Lacassie Y; Gómez R; Vargas A; Barkemeyer B; Kanotra S; Zambrano RM
    Eur J Med Genet; 2016 Apr; 59(4):227-31. PubMed ID: 26855056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium signaling regulates trafficking of familial hypocalciuric hypercalcemia (FHH) mutants of the calcium sensing receptor.
    Grant MP; Stepanchick A; Breitwieser GE
    Mol Endocrinol; 2012 Dec; 26(12):2081-91. PubMed ID: 23077345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mutation in calcium-sensing receptor gene associated to hypercalcemia and hypercalciuria.
    Mastromatteo E; Lamacchia O; Campo MR; Conserva A; Baorda F; Cinque L; Guarnieri V; Scillitani A; Cignarelli M
    BMC Endocr Disord; 2014 Oct; 14():81. PubMed ID: 25292184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GENETICS IN ENDOCRINOLOGY: Gain and loss of function mutations of the calcium-sensing receptor and associated proteins: current treatment concepts.
    Mayr B; Schnabel D; Dörr HG; Schöfl C
    Eur J Endocrinol; 2016 May; 174(5):R189-208. PubMed ID: 26646938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel homozygous inactivating mutation of the calcium-sensing receptor gene (CASR) in neonatal severe hyperparathyroidism-lack of effect of cinacalcet.
    Atay Z; Bereket A; Haliloglu B; Abali S; Ozdogan T; Altuncu E; Canaff L; Vilaça T; Wong BY; Cole DE; Hendy GN; Turan S
    Bone; 2014 Jul; 64():102-7. PubMed ID: 24735972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.